
Setting New Benchmarks in Proteomics
Proteoforms: functional variants of a protein
Tau proteinNo modification
Chemical modification
A vast landscape of proteoforms governs every stage of disease: progression, resolution, drug response, and biomarker signals.
TRIAMS™ platform
A revolutionary platform that combines the advantages of two state-of-the-art techniques
At ProQomics, we seamlessly integrate two cutting-edge protein quantification technologies: multiplexed immunoarrays and LC-MS, overcoming their individual limitations to forge a powerful high-throughput technique. Our unique approach allows for the direct measurement of proteoforms, rather than relying on proxy measurements, setting a new standard in the field. This innovation not only increases the throughput but also enhances the sensitivity, offering an unparalleled tool for precise proteoform analysis.
TRIAMS™ (Three-dimensional Immuno Array Mass Spectrometry): leveraging proven scientific principles

Step 1
Multiplexed affinity capture using barcoded reagents
ProQ™ Reagents

Step 2
Novel 3D immuno array
ProQFiler™ instrument
High-Resolution MS
Step 3
Mass spectrometry analysis

Step 4
Data analysis
ProQintelli™ AI-enabled software suite
Advantages of the ProQomics Platform
Specificity
High-confidence proteoform data
Scalability
Customizable to any number of proteoforms
Comprehensive
Quantitation of up to 30,000 proteoforms
Quantitation
True quantitation using internal and reference standards
Sensitivity
Quantitation at sub-attomolar levels
High-throughput
Designed for 2,000 proteoforms per minute
Proteoform
First platform for high-throughput quantitation of proteoforms
Reproducibility
Highly reproducible mass spectrometry analysis
Dynamic range
Quantitation by competitive binding offers broad dynamic range